Transforming disease and drug research
AI-driven computational disease models
"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "
"“We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general inquiries.“"
""We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also the team is well engaged, and had a very good understanding in the background of the project and our research question""
"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day to day mission of bringing innovation into Teva."
"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target evaluation meetings."
"We find that the Euretos group was very easy to work with and communicate with. The professional staff at Euretos did a great job extending their bioinformatics platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."
We work closely together with many pharmaceutical & biotech companies, especially in target discovery and indication selection. We generate data-driven disease insights through a unique combination of AI-driven, computational disease models, translational biology consultancy and direct access by our client's domain experts to the Euretos AI platform.
Discover and evaluate novel targets for your disease of interest by the unique combination of Euretos molecular disease models and direct access to the Euretos AI Platform.